Both in Pharmaceuticals
Maravai LifeSciences Holdings vs Verastem
Over the past year MRVI returned +171.3% and VSTM returned +24.5%; their daily moves had a correlation of -0.00.
MRVI +171.3% VSTM +24.5%Growth of $1, one year, split-adjusted
| Metric | MRVI | VSTM |
|---|---|---|
| Price | $7.79 | $9.85 |
| Market cap | $1.16B | $1.20B |
| Today | +4.50% | +0.82% |
| 1 month | −0.8% | +27.1% |
| 6 months | +97.6% | +63.9% |
| Year to date | +139.5% | +27.6% |
| 1 year | +164.8% | −0.5% |
| Revenue growth (YoY) | +8.5% | +1775.4% |
| Gross margin | 40.1% | 89.9% |
| Net margin | −24.1% | −86.5% |
| P/E (TTM) | — | — |
| Price / sales | 5.6× | 13.7× |
| Net cash | -$106.6M | $54.6M |
| Dividend yield | — | — |
| Volatility (60d) | 86.4% | 69.3% |
| Short % of float | 10.7% | 20.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).